Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Prolaio

Explore full profile

Cardiovascular clinical research infrastructure with continuous wearable data and FDA-cleared digital biomarkers

Chicago, United StatesFounded 2022Health Tech & Medtech
Valuation $100–250M Last recorded · 2023
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Prolaio and the history behind them.

About Prolaio

Prolaio builds cardiovascular clinical research infrastructure that turns homes into trial sites: medical-grade wearables and devices capture continuous real-world heart data, and an intelligence engine converts those signals into clinically robust endpoints and FDA-cleared digital biomarkers. Sponsors use the platform across recruitment, 24/7 data capture, adaptive trial analytics, and clinical trial reporting dashboards — from fully managed real-world trials to digital enablement of existing protocols and post-discharge monitoring. The company reports dozens of proven algorithms including multiple FDA-cleared measures (e.g. multivariate change index, AFib burden, blood pressure, heart rate, respiration rate, QRS, eVO2peak) on a large curated cardiovascular dataset across 20+ countries.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2022
Headquarters
Chicago, United States
Employees
85
Open positions
16
Dealroom signal
91.4/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Hard Tech
Technology
Big Data
Business model
SaaS
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Mar 2025 $0 — Kardigan ↗
EARLY VC✓Equity / VC Jul 2023 $26M $102M Undisclosed ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Prolaio website traffic

Latest recorded traffic for Prolaio is 62K monthly website visits, down 11.4% over the last three months. Prolaio's team grew 19.7% over the past year.

Latest monthly visits62K 3-month web change-11.4% 1-year team growth+19.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors1 additional known investor

  • Kardigan
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States96.9%
🇪🇸 Spain1.5%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Prolaio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Prolaio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.